Form D · Biotechnology
Aquaro Histology, Inc.
Ann Arbor, MI · CIK 0001707807
Offering snapshot reported Jun 7, 2017 · SEC filing
- Reported sold
- $9.81M Offering amount: $9.81M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 31, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2017 | Initial | $9,810,879 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-288230
Source: Form D, filed Jun 7, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Ball | Director, Executive |
| Alberto Elli | Director, Executive |
| Rob Hart | Director |
| Deval Lashkari | Director |
| Thomas Raffin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1777 Highland Drive Suite F
Ann Arbor, MI, 48108
Ann Arbor, MI, 48108